- software firm specializing in the pharmaceutical industry
Veeva VEEV +0.51% climbed 85.8% to close at $37.16. The Pleasanton, Calif.-based company began trading on the New York Stock Exchange. Veeva priced its IPO at $20 a share, above its revised range of $16 to $18. The company, which is geared to the life sciences market, had initially set a range of $12 to $14.
Founded in 2007, the company offers Web-based applications that help pharmaceutical and biotech companies manage content and customer relations.
Veeva Systems founder and CEO Peter Gassner
Unlike traditional software vendors, Veeva makes software applications available on a peruser, per-month basis. The company is part of a wave in IT in which businesses access computing power through a network and pay for computing access they need and use, thus avoiding the expense of setting up data centers.
Veeva co-founder and Chief Executive Peter Gassner witnessed the growth of the trend as a veteran of the tech industry, including Salesforce.com (CRM), known as a pioneer of the software-as-a-service model.
Gassner said he also saw opportunity in industry-specific applications and decided to start Veeva with the life-sciences market in mind.
“Some of the most important applications out there are industry-specific applications,” he told MarketWatch. “You can have strong revenue growth and strong profit in a cloud computing company. That’s what’s generating enthusiasm.”
For its fiscal year ended Jan. 31 2013, Veeva posted a net income of about $19 million, on revenue of roughly $130 million, compared with a profit of $4 million, and revenue of $61 million in the year-earlier period.
Another cloud-based company, Textura Corp. (TXTR), which offers Web-based applications to contractors and construction firms, has its stock soar nearly threefold since going public in June with an IPO price of $15.
No comments:
Post a Comment